LightOx Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $117K

  • Investors
  • 12

LightOx General Information

Description

Developer of light-activated therapeutics and technology designed to improve patients' function and long-term outcomes. The company offers light-activated therapies targeting oral pre-cancer, antimicrobial applications, and a light-activated spray for wound care, enabling patients, healthcare providers, and emergency medical teams, enabling treatment of oral disease, infections, and traumatic injuries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 65 Westgate Road
  • Newcastle upon Tyne NE1 1SG
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 65 Westgate Road
  • Newcastle upon Tyne NE1 1SG
  • England, United Kingdom

LightOx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LightOx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Accelerator/Incubator 01-Jan-2026 $117K Completed Pre-Clinical Trials
11. Accelerator/Incubator Completed Pre-Clinical Trials
10. Later Stage VC (Series A) 03-May-2024 Completed Pre-Clinical Trials
9. Grant 06-Jun-2023 Completed Pre-Clinical Trials
8. Grant 01-Jan-2022 Completed Pre-Clinical Trials
7. Seed Round 12-Oct-2021 Completed Pre-Clinical Trials
6. Grant 01-Jun-2020 Completed Pre-Clinical Trials
5. Grant 01-Dec-2019 Completed Pre-Clinical Trials
4. Seed Round 02-May-2019 $467K $467K Completed Pre-Clinical Trials
3. Angel (individual) 01-Jan-2018 Completed Pre-Clinical Trials
To view LightOx’s complete valuation and funding history, request access »

LightOx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
A1 Ordinary
A1 Ordinary
Ordinary 288 $0.125071 $254.1 $254.1 1x $254.1 0.67%
Ordinary 3,655 $0.125071 $122.65 $122.65 1x $122.65 8.5%
To view LightOx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LightOx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of light-activated therapeutics and technology designed to improve patients' function and long-term outcomes.
Drug Discovery
Newcastle upon Tyne, United Kingdom
17 As of 2026

Ness Ziona, Israel

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LightOx Competitors (4)

One of LightOx’s 4 competitors is ImPact Biotech, a Corporation company based in Ness Ziona, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImPact Biotech Corporation Ness Ziona, Israel
Aura Biosciences Formerly VC-backed Boston, MA
Rakuten Medical Venture Capital-Backed San Diego, CA
Photocure Corporate Backed or Acquired Oslo, Norway
To view LightOx’s complete competitors history, request access »

LightOx Patents

LightOx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202313555-D0 Compositions and methods for the treatment and prevention of bacterial infections casued by gram-positive bacteria Inactive 05-Sep-2023
AU-2024337829-A1 Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria Pending 05-Sep-2023
EP-4773964-A1 Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria Pending 05-Sep-2023
JP-2026530107-A Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria Pending 05-Sep-2023
WO-2025051640-A1 Compositions and methods for the treatment and prevention of bacterial infections caused by gram-positive bacteria Inactive 05-Sep-2023 A61K31/496
To view LightOx’s complete patent history, request access »

LightOx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LightOx Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Diana (UK) Accelerator/Incubator Minority
Pxn Ventures Corporate Venture Capital Minority
NG Bio (UK) Venture Capital Minority
Northstar Ventures Venture Capital Minority
Innovate UK Government
You’re viewing 5 of 12 investors. Get the full list »

LightOx FAQs

  • When was LightOx founded?

    LightOx was founded in 2016.

  • Where is LightOx headquartered?

    LightOx is headquartered in Newcastle upon Tyne, United Kingdom.

  • What is the size of LightOx?

    LightOx has 17 total employees.

  • What industry is LightOx in?

    LightOx’s primary industry is Drug Discovery.

  • Is LightOx a private or public company?

    LightOx is a Private company.

  • What is LightOx’s current revenue?

    The current revenue for LightOx is .

  • How much funding has LightOx raised over time?

    LightOx has raised $4.62M.

  • Who are LightOx’s investors?

    Diana (UK), Pxn Ventures, NG Bio (UK), Northstar Ventures, and Innovate UK are 5 of 12 investors who have invested in LightOx.

  • Who are LightOx’s competitors?

    ImPact Biotech, Aura Biosciences, Rakuten Medical, and Photocure are competitors of LightOx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process